FCC
KURA icon

Flower City Capital’s Kura Oncology KURA Stock Holding History

Flower City Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Hold
18,000
– – 0.09% 46
2026
Q1 		$146K Buy
18,000
+6,000
+50% +$51.5K 0.07% 44
2025
Q4 		$125K Buy
12,000
+2,000
+20% +$21K 0.06% 42
2025
Q3 		$88.5K Hold
10,000
– – 0.05% 41
2025
Q2 		$57.7K Sell
10,000
-2,000
-17% -$12.3K 0.03% 39
2025
Q1 		$79.2K Buy
+12,000
New +$93.5K 0.05% 37

Other funds holding KURA

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
XWM
Xcel Wealth Management Holly Hill, Florida $419M AUM 30.44% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Flower City Capital's KURA Position: Q2 2026 in Review

Flower City Capital held its Kura Oncology (KURA) position steady in Q2 2026 at 18,000 shares worth $197K. The position accounts for 0.09% of the portfolio, ranked #46.

Flower City Capital first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. 42 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Flower City Capital held 18,000 shares of Kura Oncology worth $197K as of Q2 2026.
  • Flower City Capital left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up 0.09% of Flower City Capital's portfolio in Q2 2026, its #46 holding.
  • Flower City Capital first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • 42 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Flower City Capital's 13F filing for Q2 2026, filed 7 Jul 2026.